Fibrosis therapy(Macomics Ltd)

N/A

Report date: 2026/01/07 15:38:16

Base Information

Drug NameFibrosis therapy(Macomics Ltd)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionExtracellular matrix protein degraders
TargetsExtracellular matrix protein
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMacomics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMacomics Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary FibrosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A